Sapiens International Corp. (SPNS) PT Raised to $16.00
Sapiens International Corp. (NASDAQ:SPNS) had its target price raised by research analysts at Needham & Company LLC from $15.00 to $16.00 in a report issued on Tuesday. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s target price would indicate a potential upside of 16.28% from the stock’s previous close.
A number of other research firms have also recently commented on SPNS. Zacks Investment Research raised Sapiens International Corp. from a “sell” rating to a “hold” rating in a report on Thursday, August 25th. Credit Suisse Group AG began coverage on Sapiens International Corp. in a research report on Wednesday, October 19th. They set an “outperform” rating for the company. Finally, Barclays PLC raised their price objective on Sapiens International Corp. from $14.00 to $15.00 and gave the company an “overweight” rating in a research report on Friday, August 5th. Two equities research analysts have rated the stock with a sell rating and three have assigned a buy rating to the company’s stock. Sapiens International Corp. currently has an average rating of “Hold” and an average price target of $13.75.
Shares of Sapiens International Corp. (NASDAQ:SPNS) opened at 13.76 on Tuesday. The stock has a 50 day moving average price of $13.24 and a 200-day moving average price of $12.72. The company has a market cap of $673.52 million, a price-to-earnings ratio of 32.22 and a beta of 0.60. Sapiens International Corp. has a 1-year low of $8.93 and a 1-year high of $14.13.
Sapiens International Corp. (NASDAQ:SPNS) last posted its quarterly earnings results on Monday, November 7th. The company reported $0.12 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.12. The business had revenue of $565 million for the quarter, compared to analysts’ expectations of $55.16 million. Sapiens International Corp. had a return on equity of 12.47% and a net margin of 10.30%. The business’s quarterly revenue was up 20.1% on a year-over-year basis. During the same period last year, the firm earned $0.12 earnings per share. Equities research analysts forecast that Sapiens International Corp. will post $0.49 earnings per share for the current year.
A number of hedge funds have recently made changes to their positions in SPNS. Denver Investment Advisors LLC increased its stake in shares of Sapiens International Corp. by 31.5% in the second quarter. Denver Investment Advisors LLC now owns 786,478 shares of the company’s stock valued at $9,210,000 after buying an additional 188,402 shares during the last quarter. Emerald Acquisition Ltd. purchased a new stake in shares of Sapiens International Corp. during the second quarter valued at about $2,087,000. Royal Bank of Canada increased its stake in shares of Sapiens International Corp. by 18.4% in the second quarter. Royal Bank of Canada now owns 512,600 shares of the company’s stock valued at $6,003,000 after buying an additional 79,670 shares during the last quarter. BlackRock Fund Advisors increased its stake in shares of Sapiens International Corp. by 6.3% in the third quarter. BlackRock Fund Advisors now owns 667,535 shares of the company’s stock valued at $8,524,000 after buying an additional 39,358 shares during the last quarter. Finally, Avalon Advisors LLC purchased a new stake in shares of Sapiens International Corp. during the first quarter valued at about $405,000. 12.96% of the stock is owned by institutional investors and hedge funds.
About Sapiens International Corp.
Sapiens International Corporation N.V. (Sapiens) is a provider of software solutions for the insurance industry, with a focus on the financial services sector. The Company operates in provider of software solutions segment. Its software solutions portfolio consists of Life, Pension, Annuity and Retirement Solutions, including software solutions for the management of a range of products for life, pension, annuity and retirement; Property and Casualty/General Insurance Solutions, including a software suite of solutions, supporting a range of business lines, including personal, commercial and specialty lines, as well as a solution for the management of reinsurance contracts; Sapiens DECISION, which is a business decision management solution, and Technology-Based Solutions, such as Sapiens eMerge.
Receive News & Stock Ratings for Sapiens International Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International Corp. and related stocks with our FREE daily email newsletter.